| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of MYCN mRNA" | 26377693 |
| C548651 | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester | 2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of MYCN mRNA | 19933214 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA" | 25510870 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "2,2',3',4,4',5-hexachlorobiphenyl results in decreased expression of MYCN mRNA" | 23829299 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of MYCN mRNA" | 19114083 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA" | 25510870 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [IGF1 protein results in increased expression of MYCN protein] | 12569580 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA" | 25510870 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "2,5,2',5'-tetrachlorobiphenyl results in increased expression of MYCN mRNA" | 23829299 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of MYCN mRNA" | 18648102 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C558529 | 9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-2(1H)-one | "9-(6-aminopyridin-3-yl)-1-(3-(trifluoromethyl)phenyl)benzo(h)(1,6)naphthyridin-2(1H)-one results in decreased expression of MYCN protein" | 22789543 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of MYCN mRNA | 17585979 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of MYCN mRNA | 16483693 |
| D000966 | Antimony Potassium Tartrate | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate | 10348353 |
| D000966 | Antimony Potassium Tartrate | MYCN protein results in decreased susceptibility to Antimony Potassium Tartrate | 10348353 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of MYCN mRNA | 24449571 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of MYCN mRNA | 12478894|2468527 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of MYCN mRNA | 20458559 |
| C015001 | arsenite | arsenite results in decreased expression of MYCN mRNA | 18929588 |
| C015001 | arsenite | TRP53 protein affects the reaction [arsenite results in decreased expression of MYCN mRNA] | 18929588 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of MYCN mRNA | 17404688 |
| C044887 | beta-methylcholine | beta-methylcholine affects the expression of MYCN mRNA | 21179406 |
| C006780 | bisphenol A | bisphenol A affects the expression of MYCN mRNA | 20170705 |
| C006780 | bisphenol A | bisphenol A results in increased expression of MYCN mRNA | 29275510 |
| C006780 | bisphenol A | bisphenol A affects the methylation of MYCN promoter | 27334623 |
| C006780 | bisphenol A | bisphenol A affects the expression of MYCN mRNA | 25181051 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of MYCN mRNA | 25270620 |
| C018475 | butyraldehyde | butyraldehyde results in increased expression of MYCN mRNA | 26079696 |
| D019256 | Cadmium Chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA | 12634122 |
| D020111 | Chlorodiphenyl (54% Chlorine) | Chlorodiphenyl (54% Chlorine) results in decreased expression of MYCN mRNA | 25270620 |
| D002737 | Chloroprene | Chloroprene results in decreased expression of MYCN mRNA | 23125180 |
| D004390 | Chlorpyrifos | [Copper co-treated with Chlorpyrifos] results in increased expression of MYCN mRNA | 21356183 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYCN mRNA | 20938992 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MYCN gene | 20938992 |
| C023600 | chromic oxide | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA | 12634122 |
| C017133 | chromous chloride | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA | 12634122 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of MYCN mRNA | 25270620 |
| D003033 | Coal Tar | Coal Tar results in increased expression of MYCN mRNA | 27858113 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of MYCN mRNA | 24386269 |
| D003300 | Copper | [Copper co-treated with Chlorpyrifos] results in increased expression of MYCN mRNA | 21356183 |
| D003300 | Copper | Copper results in increased expression of MYCN mRNA | 21356183 |
| C551994 | crizotinib | crizotinib inhibits the reaction [ALK protein results in increased expression of MYCN mRNA] | 22286764 |
| C551994 | crizotinib | crizotinib inhibits the reaction [ALK protein results in increased expression of MYCN protein] | 22286764 |
| D003471 | Cuprizone | Cuprizone results in increased expression of MYCN mRNA | 26577399 |
| C007262 | deoxynivalenol | deoxynivalenol affects the phosphorylation of MYCN protein | 23352502 |
| D003976 | Diazinon | Diazinon affects the expression of MYCN mRNA | 22546817 |
| D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in decreased expression of MYCN mRNA | 28962523 |
| D004026 | Dieldrin | Dieldrin affects the expression of MYCN mRNA | 22546817 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of MYCN mRNA | 21852083 |
| D004041 | Dietary Fats | resveratrol inhibits the reaction [Dietary Fats results in increased expression of MYCN mRNA] | 21852083 |
| C014476 | diethyl maleate | diethyl maleate results in decreased expression of MYCN mRNA | 25270620 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MYCN mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of MYCN mRNA | 24535843 |
| D004317 | Doxorubicin | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Doxorubicin | 10348353 |
| D004317 | Doxorubicin | MYCN protein results in decreased susceptibility to Doxorubicin | 10348353 |
| C118739 | entinostat | entinostat results in increased expression of MYCN mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of MYCN mRNA | 20170705|2686566 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of MYCN mRNA | 18936297 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of MYCN mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of MYCN mRNA | 20170705|2686566 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of MYCN mRNA | 15576828 |
| C024565 | ethylene dichloride | ethylene dichloride results in decreased expression of MYCN mRNA | 28189721 |
| D005047 | Etoposide | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Etoposide | 10348353 |
| D005047 | Etoposide | MYCN protein results in decreased susceptibility to Etoposide | 10348353 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of MYCN mRNA | 19272435 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYCN mRNA | 20938992 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MYCN gene | 20938992 |
| D004397 | Fonofos | Fonofos results in increased methylation of MYCN promoter | 22847954 |
| C039281 | furan | furan results in increased methylation of MYCN gene | 22079235 |
| D019833 | Genistein | Genistein affects the expression of MYCN mRNA | 26865667 |
| C568713 | GSK1210151A | GSK1210151A results in decreased expression of MYCN mRNA | 24952595 |
| D006534 | Heptachlor Epoxide | Heptachlor Epoxide results in decreased expression of MYCN mRNA | 25270620 |
| C538724 | HhAntag691 | MYCN protein results in decreased susceptibility to HhAntag691 | 24973920 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of MYCN mRNA | 20003209 |
| C561695 | (+)-JQ1 compound | [(+)-JQ1 compound co-treated with panobinostat] results in decreased expression of MYCN mRNA | 26733615 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound inhibits the reaction [BRD4 protein binds to MYCN promoter] | 23430699 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound promotes the reaction [panobinostat results in decreased expression of MYCN protein] | 26733615 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of MYCN mRNA | 23430699|2495259 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of MYCN protein | 23430699|2673361 |
| C561695 | (+)-JQ1 compound | MYCN protein affects the susceptibility to (+)-JQ1 compound | 25535366 |
| C561695 | (+)-JQ1 compound | MYCN protein results in increased susceptibility to (+)-JQ1 compound | 23430699 |
| C561695 | (+)-JQ1 compound | panobinostat inhibits the reaction [(+)-JQ1 compound results in decreased expression of MYCN protein] | 26733615 |
| C561695 | (+)-JQ1 compound | panobinostat promotes the reaction [(+)-JQ1 compound results in decreased expression of MYCN protein] | 26733615 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of MYCN mRNA | 24297863|2497392 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of MYCN protein | 24297863 |
| C561695 | (+)-JQ1 compound | MYCN protein results in increased susceptibility to (+)-JQ1 compound | 24297863 |
| D007649 | Ketamine | Ketamine results in decreased expression of MYCN mRNA | 20080153 |
| C561435 | LDE225 | MYCN protein results in decreased susceptibility to LDE225 | 24973920 |
| C008261 | lead acetate | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA | 12634122 |
| C045463 | leflunomide | leflunomide results in increased expression of MYCN mRNA | 19751817 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MYCN mRNA | 20938992 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of MYCN gene | 20938992 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of MYCN mRNA | 23179753|2627250 |
| C004925 | methylmercuric chloride | "[NOG protein co-treated with methylmercuric chloride co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| D018817 | N-Methyl-3,4-methylenedioxyamphetamine | "N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of MYCN mRNA" | 20188158 |
| C550258 | MLN 8237 | MLN 8237 results in decreased expression of MYCN protein | 25174395 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in decreased expression of MYCN mRNA | 16809437 |
| C016599 | mono-(2-ethylhexyl)phthalate | mono-(2-ethylhexyl)phthalate results in increased expression of MYCN mRNA | 16809437 |
| C523799 | MRK 003 | MRK 003 results in increased expression of MYCN mRNA | 21169257 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in increased expression of MYCN mRNA" | 25554681 |
| C022838 | nickel chloride | nickel chloride affects the expression of MYCN mRNA | 22546817 |
| C516714 | NVP-TAE684 | NVP-TAE684 inhibits the reaction [ALK protein results in increased expression of MYCN mRNA] | 22286764 |
| C516714 | NVP-TAE684 | NVP-TAE684 inhibits the reaction [ALK protein results in increased expression of MYCN protein] | 22286764 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of MYCN mRNA | 26516004 |
| C496932 | panobinostat | [(+)-JQ1 compound co-treated with panobinostat] results in decreased expression of MYCN mRNA | 26733615 |
| C496932 | panobinostat | (+)-JQ1 compound promotes the reaction [panobinostat results in decreased expression of MYCN protein] | 26733615 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat inhibits the reaction [(+)-JQ1 compound results in decreased expression of MYCN protein] | 26733615 |
| C496932 | panobinostat | panobinostat promotes the reaction [(+)-JQ1 compound results in decreased expression of MYCN protein] | 26733615 |
| C496932 | panobinostat | panobinostat results in decreased expression of MYCN protein | 26733615 |
| C496932 | panobinostat | panobinostat results in increased expression of MYCN mRNA | 26272509 |
| D010278 | Parathion | Parathion results in increased methylation of MYCN promoter | 22847954 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of MYCN mRNA" | 25510870 |
| C101814 | perfluoro-n-undecanoic acid | perfluoro-n-undecanoic acid results in increased expression of MYCN mRNA | 23602845 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of MYCN mRNA | 24535843 |
| D010634 | Phenobarbital | Phenobarbital results in decreased expression of MYCN mRNA | 23091169 |
| D059808 | Polyphenols | Polyphenols results in increased expression of MYCN mRNA | 16293270 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in decreased expression of MYCN mRNA | 28903501 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of MYCN mRNA | 17404688 |
| D011374 | Progesterone | Progesterone results in decreased expression of MYCN mRNA | 22238285 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of MYCN mRNA | 24780913 |
| C450682 | R116010 | R116010 promotes the reaction [Isotretinoin results in decreased expression of MYCN mRNA] | 17486130 |
| C450682 | R116010 | R116010 promotes the reaction [Tretinoin results in decreased expression of MYCN mRNA] | 17486130 |
| C450682 | R116010 | R116010 results in increased expression of MYCN mRNA | 17486130 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Dietary Fats results in increased expression of MYCN mRNA] | 21852083 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of MYCN mRNA | 17486130 |
| D015474 | Isotretinoin | R116010 promotes the reaction [Isotretinoin results in decreased expression of MYCN mRNA] | 17486130 |
| C009166 | retinol acetate | retinol acetate results in increased expression of MYCN mRNA | 16772331 |
| D012834 | Silver | Silver results in decreased expression of MYCN mRNA | 27131904 |
| C009277 | sodium arsenate | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to sodium arsenate | 10348353 |
| C009277 | sodium arsenate | MYCN protein results in decreased susceptibility to sodium arsenate | 10348353 |
| C017947 | sodium arsenite | sodium arsenite affects the methylation of MYCN gene | 28589171 |
| C017947 | sodium arsenite | [sodium arsenite co-treated with Cadmium Chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in decreased expression of MYCN mRNA | 12634122 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of MYCN mRNA | 12016162 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of MYCN mRNA | 11241755 |
| D053260 | Soot | Soot results in decreased expression of MYCN mRNA | 26551751 |
| C012568 | terbufos | terbufos results in increased methylation of MYCN promoter | 22847954 |
| D043343 | Testosterone Propionate | Testosterone Propionate results in decreased expression of MYCN mRNA | 15601916 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of MYCN mRNA | 17035482|1993321 |
| D019284 | Thapsigargin | Thapsigargin results in decreased expression of MYCN mRNA | 22378314 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MYCN mRNA | 18230668 |
| D014212 | Tretinoin | R116010 promotes the reaction [Tretinoin results in decreased expression of MYCN mRNA] | 17486130 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MYCN | 17283129 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MYCN mRNA | 17229153|1748613 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of MYCN mRNA | 16604517 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of MYCN mRNA | 24935251 |
| C012589 | trichostatin A | trichostatin A results in increased expression of MYCN mRNA | 24935251|2627250 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in decreased expression of MYCN mRNA | 19042947 |
| C046243 | tryptanthrine | tryptanthrine results in decreased expression of MYCN mRNA | 23500671 |
| C046243 | tryptanthrine | tryptanthrine results in decreased expression of MYCN protein | 23500671 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of MYCN mRNA | 22378314 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of MYCN mRNA | 24935251 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of MYCN mRNA | 23179753|2438349 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of MYCN gene | 29154799 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of MYCN mRNA | 19136453|2054688 |
| D014750 | Vincristine | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine | 10348353 |
| D014750 | Vincristine | MYCN protein results in decreased susceptibility to Vincristine | 10348353 |
| D010205 | Pantothenic Acid | Pantothenic Acid results in increased expression of MYCN mRNA | 19397697 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of MYCN mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of MYCN mRNA | 26272509 |
| C009687 | wortmannin | wortmannin inhibits the reaction [IGF1 protein results in increased expression of MYCN protein] | 12569580 |